BioCryst Pharmaceuticals, Inc.
BCRXNASDAQNASDAQ Global Select·USD·Closed
$6.58
−$0.09 (1.35%)
$6.58
−$0.09 (1.35%)
Not investment advice.Learn more
BCRX leans slightly negative — a few concerns outweigh the positives.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near yearly low
Volume
Market Cap
Small-cap company
P/E Ratio
Cheap relative to earnings
Div Yield
No dividend